A Generous Multimillion-Dollar Gift Advances Medical Education at Mount Sinai

Peter W. May and his wife, Leni

Peter W. May and his wife, Leni, have made a generous multimillion-dollar gift in support of medical education at the Icahn School of Medicine at Mount Sinai. Steadfast champions of Mount Sinai and the future of medical education, the Mays have had a long, illustrious history of philanthropic support across numerous areas of the Health System. This commitment is the latest example of their tremendous generosity and will be recognized with the naming of the Leni and Peter W. May Department of Medical Education at Mount Sinai.

The Mays are strong advocates in bolstering the culture of innovation, service, and groundbreaking science and medicine at the Icahn School of Medicine.  Their gift will be instrumental in ensuring the School continues to provide a strong foundation to prepare physicians to advance medical care and research that will ultimately result in equitable health care and better outcomes for the diverse communities Mount Sinai serves.

“Leni and Peter have always recognized the uniqueness of our medical school, its values rooted in justice and care for the underserved, and the rigorous training we put our medical students through to ensure they are well positioned to pursue their professional ambitions,” says David Muller, MD, Dean for Medical Education and the Marietta and Charles C. Morchand Chair for Medical Education at Mount Sinai.  “We are grateful for the role this gift will play in building upon our continued success at the Icahn School of Medicine.”

During his tenure as Chairman of the Mount Boards of Trustees, Mr. May helped drive Mount Sinai’s transformation into one of the top health systems in the world, and he continues his visionary leadership as Chairman Emeritus. The May family’s tireless support of Mount Sinai was previously recognized with the naming of the May Center for Mount Sinai Doctors on East 98th Street and the Leni and Peter W. May Department of Orthopaedic Surgery. They remain committed as ever to supporting the ever-growing needs of Icahn Mount Sinai as it continues to prepare the most promising students to improve the health of communities locally and globally and to shape the future of science and medicine.

“Leni and I are happy to support the next generation of medical leaders,” says Mr. May who now serves as Chairman Emeritus of the Boards of Trustees at Mount Sinai.  “The Icahn School of Medicine provides students with an extraordinary education in a translational context, and we are proud to be a part of that.”

Mount Sinai Hosts Visit by Senior Health Official From Greece

Zoe Rapti, right, Deputy Minister of Health of Greece, and George Dangas, MD, PhD

A senior health official of the Greek government visited Mount Sinai on December 7 to learn more about how Mount Sinai responded to the COVID-19 pandemic in New York and about Mount Sinai’s cardiovascular programs in Queens, where there is a large Greek-American population.

Greek Deputy Minister of Health Zoe Rapti visited The Mount Sinai Hospital and met with David Reich, MD, President, and others, including George Dangas, MD, PhD, an interventional cardiologist who is  Director of Cardiovascular Innovation at The Zena and Michael A. Wiener Cardiovascular Institute and Professor of Medicine at the Icahn School of Medicine at Mount Sinai.

“It was a great honor to meet the health minister and to share ideas and learn from one another. Mount Sinai has a long history serving the Greek community, and we look forward to further discussions and collaboration,” said Dr. Reich, who also serves as president of Mount Sinai Queens.

Dr. Dangas, who completed medical and postgraduate studies at the National and Kapodistrian University of Athens, said they discussed a number of issues, including the ways Mount Sinai Queens serves the Greek-American population and the tremendous response mounted against the pandemic.  Ms. Rapti also had a chance to meet a patient from Chios Island—the fifth largest of the Greek islands—leaving the hospital and hear about the hospital’s highly specialized care.

They were joined by Stamatios Lerakis, MD, PhD, Director of Noninvasive Cardiology for Mount Sinai Heart, Director of Imaging for Structural and Valve Interventions for the Mount Sinai Health System, and Professor of Medicine (Cardiology), and Diagnostic, Molecular and Interventional Radiology. He also received his MD degree from the Medical School of Athens.

“We were very pleased to walk through the exact pathways of outpatient and inpatient care at Mount Sinai Heart with the minister and discuss how things have evolved over the past extraordinary years,” Dr. Dangas said.

Zoe Rapti, center, Deputy Minister of Health of Greece, with Stamatios Lerakis, MD, PhD, left, and George Dangas, MD, PhD

Mount Sinai Experts Explain What the Omicron Variant Means for You

Until very recently, you probably never heard of the term omicron. If you did, it was as a letter in the Greek alphabet, like delta or pi. Now, Omicron dominates the news as the latest coronavirus variant that was first discovered in Southern Africa and is now being found around the world, including in the United States.

Although data on the Omicron variant is incomplete, a clearer picture is beginning to emerge, note two of Mount Sinai’s leading experts in infectious diseases Judith A. Aberg, MD, Dean of System Operations for Clinical Sciences and Chief of the Division of Infectious Diseases, and Bernard Camins, MD, Medical Director for Infection Prevention.

New Guidance on COVID-19 Vaccines: In April 2023, the Food and Drug Administration and the Centers for Disease Control and Prevention announced some major changes for COVID-19 vaccines. Click here to read more about what you need to know.

What do we know about the Omicron variant?

According to Drs. Aberg and Camins, the limited evidence we have suggests that while Omicron is more transmissible than earlier variants, it causes mainly mild disease—especially in people who are fully vaccinated and who have received their booster dose. Additionally, it appears to produce symptoms in line with those expected of COVID-19. This includes fatigue and headache as well as sore throat, runny nose, coughing, and fever. If you feel any of these symptoms, please get tested

It will take more time for researchers and clinicians to fully assess how effective existing COVID-19 vaccines are against the Omicron variant. But if you have not yet been vaccinated, or are eligible and have not yet received a booster shot, you should do so as soon as possible. Vaccine makers are assessing the need to reformulate their vaccines against the new variant, but that may take months; Drs. Aberg and Camins say it is better to get some additional protection now rather than waiting for the potential for better protection later.

How do we protect ourselves against a more transmissible variant?

Drs. Aberg and Camins say that it is more important than ever to follow current guidelines from the Centers for Disease Control and Prevention (CDC) for avoiding infection, such as wearing masks in public indoor settings, staying home if you feel sick, getting vaccinated, and getting your booster shot when you are eligible. This is especially important as we enter the holiday season and as rates of infection rise in the New York metropolitan region and around the country, although there is no evidence that Omicron is the cause.

In addition, Drs. Aberg and Camins say you should be vigilant about following the CDC’s detailed guidelines on gathering for the holidays, which emphasize keeping your gatherings small and outdoors if possible. For traveling, the CDC says you should avoid travel if you have been exposed to COVID-19 unless you are fully vaccinated or recovered from COVID-19 in the past 90 days. You should avoid international travel until you are fully vaccinated. Some international travel is already being curtailed because of the new variant.

What else should be taken into consideration as this global pandemic continues?

Viruses constantly change through mutation.

These variants do not necessarily present a significant new risk. Last summer, the Delta variant was found to be more easily transmitted, but people who were vaccinated did not face a significantly increased risk of serious illness or hospitalization. Many other variants were initially thought important enough to be assigned a Greek-letter name but later turned out not to have a widespread or significant effect.

Scientists and researchers are hard at work to fully assess this variant.

Currently, scientists are working in labs to assess how effective the existing COVID-19 vaccines are against Omicron. The testing involves taking blood samples from those who have been fully vaccinated and seeing if their antibodies neutralize the new variant. Results are expected in a few weeks. Additionally, Mount Sinai researchers are continually analyzing the positive SARS-CoV-2 samples for variants, including Omicron, to see if these variants are circulating among the local population.

We are keeping an eye on the effectiveness of monoclonal antibody treatments.

One of the main concerns with the Omicron variant is that the number and type of mutations it contains may make some monoclonal antibody treatments less effective. Monoclonal antibody treatments are given to non-hospitalized people diagnosed with COVID-19 who are at high risk of developing more severe symptoms. Scientists are working to learn which treatments will be most effective against Omicron.

What You Need to Know About COVID-19 Booster Shots Now Available for All Adults


In another step to strengthen the public health defense against the COVID-19 pandemic, federal regulators have authorized “booster” shots for all adults.

The Food and Drug Administration (FDA) has authorized a booster dose for the Pfizer-BioNTech, Moderna, and Johnson & Johnson vaccines, and the Centers for Disease Control and Prevention (CDC) is recommending booster shots for all adults over age 16. Health experts are encouraging all those eligible to consider getting the booster shot.

New Guidance on COVID-19 Vaccines: In April 2023, the Food and Drug Administration and the Centers for Disease Control and Prevention announced some major changes for COVID-19 vaccines. Click here to read more about what you need to know.

“The most important thing is to get vaccinated, and get a booster shot” if you over 16, says Waleed Javaid, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai and an expert on infectious diseases. “We at Mount Sinai are closely monitoring reports on various variants including Omicron and Delta.  At this time, we encourage everyone to get vaccines and boosters, and continue to wear masks in public and follow guidance provided by the public health officials.”

Update: The Centers for Disease Control and Prevention (CDC) has strengthened its recommendation on booster shots to include everyone 16 or older when they are eligible. The CDC is working to learn more about the new Omicron variant.  The CDC continues to recommend wearing a mask in public indoor settings in areas where there are high rates of COVID-19, and getting vaccinated and booster shots for those who are eligible. Read more from the CDC

Waleed Javaid, MD

In this Q&A, Dr. Javaid answers other frequently asked questions about COVID-19 booster shots.

When should I get a booster shot?

If you were fully vaccinated with the Pfizer or the Moderna vaccine, you should get the booster at least six months after getting the two vaccine doses. If you received the Johnson & Johnson vaccine, you should get the booster at least two months after completing the primary vaccination.

What do we know about side effects from the booster shot?

I received my booster, and I had pretty much the same reaction as my second dose. Most of those around me also experienced very similar reactions as their second dose. The short-term side effects include pain in the arm where you got your shot, tiredness, and headache. There is nothing in the literature or in our experience at Mount Sinai to suggest the reaction will be any different from the first and second doses.

Does it matter which booster shot I get?

The most recent recommendation from the FDA and the CDC is that we can use these vaccines interchangeably, and they have not found one is better than the other. Right now, they are considered equal.

What if I got the J&J vaccine?

People who have received a single dose of the Johnson & Johnson vaccine can get a booster using the Johnson & Johnson vaccine, or they can get a Pfizer or Moderna dose as a booster. However, as of Thursday, December 16, the CDC recommends that patients receive an mRNA COVID-19 vaccine over Johnson & Johnson’s COVID-19 vaccine due to the increased effectiveness of mRNA vaccines.

What is the difference between a booster shot and a third dose?

A third shot is considered part of the original series and is considered necessary to provide full protection to a group of people who have reduced ability to fight infections, which includes patients being treated for some cancers or those with an organ transplant. Boosters are shots that have now been authorized for all adults after a certain time period has passed since they were fully vaccinated in order to boost their immune system to ensure they can continue to fight the infection. Right now, a booster shot is not required to be considered fully vaccinated if you are not among the special group specifically recommended for a third shot.

I’ve had COVID-19 and two doses of the vaccine, should I get the booster shot?

People who have had COVID-19 and got two doses of vaccine can certainly get their booster shot. There seem to be questions about this. The data shared by the CDC and other agencies is that getting the booster shot after being infected with COVID-19 offers you additional protection against infection. To all adults, I would say, definitely consider a booster as an option to protect yourself and your loved ones around you. I encourage everybody to reach out to their providers or to Mount Sinai for any advice we can provide.

Cullman Family Award for Excellence in Physician Communication Honors Outstanding Providers


For the past six years, the Cullman Family Award for Excellence in Physician Communication has honored Mount Sinai Health System physicians and advanced practice providers who demonstrate exceptional communication in clinical practice. This year 74 outstanding Mount Sinai providers were honored, more than ever before.

Recipients of this year’s award were ranked in the top one percent nationally in provider communication for 2020 as measured by the Centers for Medicare and Medicaid Services’ Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) patient experience survey.

Patients’ Tributes to Cullman Award honorees

“She listened to all my needs and was kind enough to understand all my anxieties.”

“He reassured me it would be all right, and he was so kind and compassionate. I was tormented in pain, and he gave me back my life.”

“I felt very cared for. Communication and bedside manner are things you hear about, but until you experience the real thing, I had no idea the affect it would have on my health and on my life.”

The awardees, listed below, were honored at a virtual ceremony on Monday, November 8. Thirty-one of the honorees—42 percent—are prior recipients, and six of them have won the awards in three or more years.

This year’s ceremony was hosted by Erica Rubinstein, MS, LCSW, CPXP, Vice President of Service Excellence and Patient Experience, and Stephen Fecteau, Senior Manager, Talent Development and Learning. The event included a special and moving video featuring patients speaking about why they nominated some of the honorees and tributes from Susan and Edgar Cullman, Jr., whose father, Edgar Cullman Sr., conceived of a program dedicated to patient experience at Mount Sinai 20 years ago.

“We are particularly proud of these providers whose goal is to put patients at the center of everything they do,” Ms. Rubinstein said of the honorees. “Their commitment to the Mount Sinai values—safety, empathy, creativity, teamwork, equality and agility—is on display every day.”

 

Mount Sinai Begins Offering COVID-19 Vaccines to Young Children

Soon after receiving the go-ahead from federal and state regulators, Mount Sinai moved quickly last week to begin offering vaccines to children age 5 to 11.

This was a moment that parents—including many in the Mount Sinai community—had been waiting for, a step toward ending the pandemic and moving back toward a more normal life. Vaccines for children age 12 to 15 were authorized in May. The Food and Drug Administration (FDA) first authorized COVID-19 vaccines for adults in December 2020.

Lower dose Pfizer-BioNTech COVID-19 vaccines were offered at special pods at The Mount Sinai Hospital and Mount Sinai Beth Israel, and Mount Sinai South Nassau used its popular Vaxmobile to deliver shots to children in the neighboring communities.

“COVID-19 has significantly affected our children in so many ways—even those who have not been sick have endured effects on their emotional and mental health, decreased physical activity, the loss of in-person learning and, for some, the loss of parents or other caregivers,” says Vicki R. LoPachin, MD, MBA, Senior Vice President, Chief Medical Officer, Mount Sinai Health System. “But the data show this vaccine to have very high efficacy at reducing infections and producing strong antibody responses, so we are confident it will be effective at preventing hospitalizations and deaths in our most vulnerable young ones. We encourage all of you who have children in your families to speak to your child’s health care provider, and schedule vaccination appointments as soon as you can.”

One focus at the outset was offering vaccinations to high-risk and the most vulnerable pediatric patients like Lexi Isler, who was born without a bladder and underwent a series of medical procedures before receiving a kidney transplant from her father, Luther, at Mount Sinai in early 2019.

“This is a great day. Having the vaccine relieves some of the mental stress,” her father said, standing beside his daughter after she received the vaccine. “We always wondered about her compromised immune system, and now we don’t have to worry quite as much with this extra layer of protection.” Lexi said she looks forward to going more places, including those that require vaccination. Immunocompromised people, such as transplant patients or those being treated for some cancers, have a reduced ability to fight infections and are more vulnerable to severe COVID-19.

To make an appointment at Mount Sinai for vaccination for anyone age 5 and older, click here. In addition, check the New York State, New York City, New Jersey, or Connecticut websites for other locations that offer appointments or walk-in vaccination. New York City is also offering in-home vaccinations for all residents 12 and over, as well as mobile vaccination vans

 

Mount Sinai is very pleased to now be able to offer the Pfizer-BioNTech COVID-19 vaccine for children age 5 to 11, says Lisa M. Satlin, MD, the Herbert H. Lehman Professor of Pediatrics and Chair of the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and Pediatrician-in-Chief of the Mount Sinai Kravis Children’s Hospital.

“Clinical studies in more than 2,000 children in this specific age group showed that the vaccine was extremely effective in preventing symptomatic COVID-19 and generated a robust antibody response,” Dr. Satlin says. “It is critical that all children—and especially those disproportionately affected by COVID-19—be vaccinated to not only protect them from the short and long-term effects of infection, but to eliminate the secondary impact of disease on in-person education and other interactions that are critical to growing children’s mental and physical well-being.”

When the Pediatric Vaccine Pod opened on Thursday, November 4, at The Mount Sinai Hospital, staff from the hospital’s Child Life and Creative Arts Therapy Department were on hand to support the children arriving for this historic opportunity, and they will continue to staff the pods as long as needed.

While the development of a COVID-19 vaccine for children age 5 to 11 brings great excitement and optimism in the fight against COVID-19, for many children getting an injection can be a scary experience.  Child Life Specialists work with children and their caregivers to identify coping strategies to mitigate fears and anxieties related to medical experiences such as vaccines.

Relaxation techniques such as deep breathing, the provision of popular items such as an iPad or bubbles to help alternate focus, and comfort positioning where a child is securely held in a caregiver’s lap, are some of the ways the child life specialists work alongside the medical team to enhance the patient experience.

Child life specialists and music therapists helped to create a supportive patient and family centered environment. Music therapists used music as a technique for coping during the injection, and also provided live music throughout the space to set a calming tone.

“This is a great opportunity to translate supportive interventions that have been impactful to our patient and families in our inpatient and outpatient environments into a new area of care,” says Licensed Music Therapist Todd O’Connor.

The Child Life and Creative Arts Therapy team makes sure that children leave their visit feeling proud of their accomplishment.  The children received a vaccine sticker along with activity books and other fun give-away items that were available for them to use during the vaccine observation period and to take home from their visit.

“We are delighted to partner in this important initiative,” says Child Life Specialist Cheryl Strauss. “We realize that the vaccine is a two-part series, and we aim to help children recognize their strengths and coping abilities for successful return visits.”

Pin It on Pinterest